The trademark application RIVIREC was filed by ITALFARMACO S.p.A., a corporation established under the laws of the Italian Republic (the "Applicant"). The application was published for oppositions on March 2, 2022, and it was registered by office on June 9, 2022 without any oppositions.
The application was filed in Italian (English was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceuticals
Pharmaceutical specialities for use in treating mild to moderate dementia caused by Alzheimer's disease
Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases, generated by or acting on the central nervous system
Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases.